In Re Edwards Lifesciences Corporation Derivative Litigation

UNITED STATES DISTRICT COURT

CENTRAL DISTRICT OF CALIFORNIA

CIVIL MINUTES — GENERAL

Case No. 8:24-cv-02822-AH (KESx) Date June 10, 2025 Title Jn re Edwards Lifesciences Corp. Derivative Litig.

Present: The Honorable Anne Hwang, United States District Judge

Yolanda Skipper —__———NotReported Deputy Clerk Court Reporter

Attorney(s) Present for Plaintiff(s): Attorney(s) Present for Defendant(s): None Present None Present

Proceedings: (IN CHAMBERS) ORDER TO SHOW CAUSE WHy CASE SHOULD

NOT BE STAYED

On October 14, 2024, Plaintiff Dhimant Patel filed a putative securities class action alleging violations of the Securities Exchange Act of 1934, 15 U.S.C. §§ 78a, et seq. (“Exchange Act”) against Edwards Lifesciences Corporation (“Edwards Lifesciences’) and corporate officers of Edwards Lifesciences. Case No. 8:24-cv-02221-AH (KESx) (the “Patel Action”), Dkt. No. 1. On December 31, 2024, Plaintiff Manh Ho filed a shareholder derivative action alleging violations of the Exchange Act, breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, and waste of…